An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

On the latest episode of the science talk show GEN Live, I was joined by a pair of experts to discuss the state of ...

The funds will support ongoing work on Fulcrum, Pairwise's gene-editing platform and efforts to create edited crops with specific traits.

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

Researchers investigated RA51C and uncovered over 3,000 harmful genetic changes that could increase cancer risk.

A new bioprocessing technique developed by a team of researchers could improve a range of therapies based on CAR-T cells.

A primary drying process model that includes the various sources of process variability can guide the process optimization ...

Filoviruses—such as Ebola and Marburg viruses—can cause hemorrhagic fevers with up to 90% lethality. Not only that, but there ...

CDMOs are willing to invest in innovative bioprocessing technologies, but the economics need to make sense. Platforms that ...

DFI therapy cost the UK’s NHS up to £962 million ($1.27 billion) each year. In the U.S., amputation cost alone is $1.38 ...

A Wyss Institute team has been selected to develop a broad-spectrum antimicrobial therapeutic under a contract from the DARPA-SHIELD program.

The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...